CDK5 inhibitor 20-223

Modify Date: 2024-01-11 18:52:28

CDK5 inhibitor 20-223 Structure
CDK5 inhibitor 20-223 structure
Common Name CDK5 inhibitor 20-223
CAS Number 865317-30-2 Molecular Weight 305.381
Density N/A Boiling Point N/A
Molecular Formula C19H19N3O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CDK5 inhibitor 20-223


CDK5 inhibitor 20-223 (CP 668863) potent, selective, ATP-competitive CDK2/5 inhibitor with IC50 of 6.0 and 8.8 nM for CDK2/CyclinE and CDK5/p35, with little to no activity against CDK1/4/6/7/9; decreases pRB (S807/811) and pFAK (S732) levels in CRC cell lines, effectively blocks the kinase activity of CDK2 and CDK5 in multiple CRC cell lines; reduces migration of CRC cells, reduces cell growth in a panel of human CRC cell lines with mean IC50 of 362 nM; effectively slows tumor progression in mice models.

 Names

Name CDK5 inhibitor 20-223

 CDK5 inhibitor 20-223 Biological Activity

Description CDK5 inhibitor 20-223 (CP 668863) potent, selective, ATP-competitive CDK2/5 inhibitor with IC50 of 6.0 and 8.8 nM for CDK2/CyclinE and CDK5/p35, with little to no activity against CDK1/4/6/7/9; decreases pRB (S807/811) and pFAK (S732) levels in CRC cell lines, effectively blocks the kinase activity of CDK2 and CDK5 in multiple CRC cell lines; reduces migration of CRC cells, reduces cell growth in a panel of human CRC cell lines with mean IC50 of 362 nM; effectively slows tumor progression in mice models.
References References 1. Robb CM, et al. Oncotarget. 2017 Dec 28;9(4):5216-5232. View Related Products by Target Cyclin-dependent Kinase (CDK)

 Chemical & Physical Properties

Molecular Formula C19H19N3O
Molecular Weight 305.381